D-Index & Metrics Best Publications
Neuroscience
Australia
2023
Biology and Biochemistry
Australia
2022

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Neuroscience D-index 130 Citations 60,173 926 World Ranking 161 National Ranking 4

Research.com Recognitions

Awards & Achievements

2023 - Research.com Neuroscience in Australia Leader Award

2022 - Research.com Biology and Biochemistry in Australia Leader Award

2015 - Fellow of the Australian Academy of Health and Medical Science

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Internal medicine
  • Enzyme

The scientist’s investigation covers issues in Biochemistry, Alzheimer's disease, Amyloid precursor protein, Amyloid and P3 peptide. The Biochemistry study combines topics in areas such as Toxicity and Cell biology. His Alzheimer's disease study is concerned with Internal medicine in general.

His research integrates issues of Molecular biology and Neurodegeneration in his study of Amyloid precursor protein. Pathology covers Colin L. Masters research in Amyloid. He combines subjects such as Biochemistry of Alzheimer's disease, Clioquinol and Transgene with his study of P3 peptide.

His most cited work include:

  • Imaging beta-amyloid burden in aging and dementia. (920 citations)
  • Imaging beta-amyloid burden in aging and dementia. (920 citations)
  • Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides. (633 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Disease, Alzheimer's disease, Internal medicine, Biochemistry and Amyloid precursor protein. He interconnects Cognition and Immunology in the investigation of issues within Disease. His Alzheimer's disease study incorporates themes from Apolipoprotein E, Dementia, Neuroscience and Degenerative disease.

His biological study spans a wide range of topics, including Endocrinology and Oncology. Colin L. Masters studied Amyloid precursor protein and Amyloid that intersect with Genetically modified mouse. The study incorporates disciplines such as Biochemistry of Alzheimer's disease and Alpha secretase in addition to P3 peptide.

He most often published in these fields:

  • Disease (27.25%)
  • Alzheimer's disease (27.88%)
  • Internal medicine (24.87%)

What were the highlights of his more recent work (between 2014-2021)?

  • Disease (27.25%)
  • Internal medicine (24.87%)
  • Neuroscience (13.06%)

In recent papers he was focusing on the following fields of study:

Colin L. Masters spends much of his time researching Disease, Internal medicine, Neuroscience, Pathology and Dementia. His Disease research incorporates elements of Cerebrospinal fluid, Microvesicles, Cell biology, Biomarker and Positron emission tomography. His Internal medicine study combines topics in areas such as Endocrinology and Oncology.

Amyloid, Clinical progression and Amyloid pet are among the areas of Pathology where Colin L. Masters concentrates his study. He has researched Dementia in several fields, including Alzheimer's disease, Gerontology and Neuropsychology. His Alzheimer's disease research is multidisciplinary, relying on both Magnetic resonance imaging, Hyperintensity and Apolipoprotein E.

Between 2014 and 2021, his most popular works were:

  • High performance plasma amyloid-β biomarkers for Alzheimer’s disease (497 citations)
  • Tau imaging: early progress and future directions (320 citations)
  • A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain (289 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Internal medicine
  • Enzyme

Colin L. Masters mainly focuses on Disease, Alzheimer's disease, Internal medicine, Apolipoprotein E and Dementia. The various areas that Colin L. Masters examines in his Alzheimer's disease study include Computational biology, Biomarker, Neurology, Neuroscience and Receiver operating characteristic. His work deals with themes such as Endocrinology, Magnetic resonance imaging and Oncology, which intersect with Internal medicine.

Colin L. Masters has included themes like Pittsburgh compound B, Amyloid beta, Senile plaques and Pathology in his Positron emission tomography study. His Amyloid research is multidisciplinary, incorporating perspectives in Machine learning and Artificial intelligence. His Amyloid precursor protein study focuses on P3 peptide in particular.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Imaging beta-amyloid burden in aging and dementia.

Christopher C Rowe;Steven Ng;Uwe Ackermann;Sylvia Gong.
Neurology (2007)

1206 Citations

High performance plasma amyloid-β biomarkers for Alzheimer’s disease

Akinori Nakamura;Naoki Kaneko;Victor L Villemagne;Takashi Kato.
Nature (2018)

993 Citations

The Amyloid Precursor Protein of Alzheimer's Disease in the Reduction of Copper(II) to Copper(I)

Gerd Multhaup;Andrea Schlicksupp;Lars Hesse;Dirk Beher.
Science (1996)

945 Citations

Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides.

Tobias Hartmann;Sophie C. Bieger;Babara Brühl;Pentti J. Tienari.
Nature Medicine (1997)

915 Citations

The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: Methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease

Kathryn A Ellis;Ashley I Bush;David Darby;Daniela De Fazio.
International Psychogeriatrics (2009)

856 Citations

Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial

Lars Lannfelt;Kaj Blennow;Henrik Zetterberg;Stellan Batsman.
Lancet Neurology (2008)

779 Citations

What the evolution of the amyloid protein precursor supergene family tells us about its function.

E.J Coulson;K Paliga;K Beyreuther;C.L Masters.
Neurochemistry International (2000)

764 Citations

Metalloenzyme-like Activity of Alzheimer's Disease β-Amyloid Cu-DEPENDENT CATALYTIC CONVERSION OF DOPAMINE, CHOLESTEROL, AND BIOLOGICAL REDUCING AGENTS TO NEUROTOXIC H2O2

Carlos Opazo;Xudong Huang;Robert A. Cherny;Robert D. Moir.
Journal of Biological Chemistry (2002)

747 Citations

Rapid Restoration of Cognition in Alzheimer's Transgenic Mice with 8-Hydroxy Quinoline Analogs Is Associated with Decreased Interstitial Aβ

Paul A. Adlard;Robert A. Cherny;Robert A. Cherny;David I. Finkelstein;David I. Finkelstein;Elisabeth Gautier.
Neuron (2008)

734 Citations

Iron-Export Ferroxidase Activity of β-Amyloid Precursor Protein Is Inhibited by Zinc in Alzheimer's Disease

James A. Duce;Andrew Tsatsanis;Michael A. Cater;Simon A. James.
Cell (2010)

710 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Colin L. Masters

Kaj Blennow

Kaj Blennow

University of Gothenburg

Publications: 390

Henrik Zetterberg

Henrik Zetterberg

University of Gothenburg

Publications: 362

Ralph N. Martins

Ralph N. Martins

Edith Cowan University

Publications: 317

Ashley I. Bush

Ashley I. Bush

Florey Institute of Neuroscience and Mental Health

Publications: 299

Victor L. Villemagne

Victor L. Villemagne

University of Pittsburgh

Publications: 235

Christopher C. Rowe

Christopher C. Rowe

University of Melbourne

Publications: 200

Reisa A. Sperling

Reisa A. Sperling

Brigham and Women's Hospital

Publications: 159

John C. Morris

John C. Morris

Washington University in St. Louis

Publications: 150

David Ames

David Ames

University of Melbourne

Publications: 146

William J. Jagust

William J. Jagust

University of California, Berkeley

Publications: 141

Kevin J. Barnham

Kevin J. Barnham

Florey Institute of Neuroscience and Mental Health

Publications: 136

Paul Maruff

Paul Maruff

University of Melbourne

Publications: 129

George Perry

George Perry

The University of Texas at San Antonio

Publications: 120

Harald Hampel

Harald Hampel

Eisai (United States)

Publications: 119

Clifford R. Jack

Clifford R. Jack

Mayo Clinic

Publications: 119

Ronald C. Petersen

Ronald C. Petersen

Mayo Clinic

Publications: 119

Trending Scientists

Achim J. Lilienthal

Achim J. Lilienthal

Technical University of Munich

J. Michael Harrison

J. Michael Harrison

Stanford University

Jianguo Lin

Jianguo Lin

Imperial College London

William R. Roush

William R. Roush

Scripps Research Institute

Markus Lackinger

Markus Lackinger

Technical University of Munich

David L. Smith

David L. Smith

University of Nebraska–Lincoln

Adam Auton

Adam Auton

23andMe (United States)

Jean-Marc Guehl

Jean-Marc Guehl

INRAE : Institut national de recherche pour l'agriculture, l'alimentation et l'environnement

Richard C. Leegood

Richard C. Leegood

University of Sheffield

Henrik Clausen

Henrik Clausen

University of Copenhagen

Ralf Langen

Ralf Langen

University of Southern California

Giovanna Ferro-Luzzi Ames

Giovanna Ferro-Luzzi Ames

University of California, Berkeley

Octavian Catuneanu

Octavian Catuneanu

University of Alberta

Gal Markel

Gal Markel

Tel Aviv University

Amanda Henderson

Amanda Henderson

Princess Alexandra Hospital

Richard Mitchell

Richard Mitchell

University of Glasgow

Something went wrong. Please try again later.